Another study in a mouse model of systemic lupus showed that PI3Kδ reduced kidney infiltration of macrophages and ameliorated lupus-like symptoms.[23] These findings indicated that PI3K inhibitors might be effective for treating LN patients. Here, PIK3CD is linked to systemic lupus erythematosus.